AUG. 18-24, 2023
A decade ago, Eli Lilly and Co. struggled to release new drugs and maintain investor interest. Today, the company is literally worth more than all of the gold in Fort Knox as its stock price continually posts new highs and analysts praise its pipeline of drugs. John Russell explores what this means for the company and Indianapolis. Also in this week’s issue, John Russell reports that one of the top researchers at Indiana University School of Medicine has been recruited away from the institution and taken more than two dozen faculty, postdoctoral associates and IU staffers with him. And Susan Orr highlights the fight against fake online consumer reviews and how the Federal Trade Commission wants to get involved.